Pantoprazol Adoh (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Adoh, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Adoh as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑oesophageal reflux disease (GERD): provides relief of heartburn and promotes healing of the oesophageal lining. - Erosive oesophagitis: accelerates mucosal healing and reduces further erosion. - Peptic ulcer disease: supports ulcer healing and helps prevent recurrence. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with the condition.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: excess gas. - Constipation: infrequent.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): requires immediate medical attention. - Clostridioides difficile infection: may present with persistent diarrhoea. - Low magnesium levels (hypomagnesemia): can cause muscle cramps or cardiac arrhythmia. - Bone fractures: long‑term use may be associated with reduced bone density. - Liver enzyme elevation: indicates possible hepatic involvement. - Acute interstitial nephritis: rare kidney inflammation.

Before starting Pantoprazol Adoh, consider the following safety points: - Assess renal function: dose adjustment may be needed in severe impairment. - Review liver status: use with caution in hepatic disease. - Monitor long‑term use: prolonged therapy has been linked to bone density loss. - Evaluate for infections: risk of gastrointestinal infections may increase. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazol Adoh may affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Antifungal agents (ketoconazole, itraconazole): reduced absorption due to higher gastric pH. - HIV protease inhibitors (atazanavir, nelfinavir): decreased efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR; monitor coagulation. - Digoxin: higher serum levels may occur; check levels periodically. - Methotrexate (high dose): reduced clearance; monitor renal function and drug levels. - Clopidogrel: diminished antiplatelet effect; consider alternative therapy.